Biolife Solutions (BLFS) Share-based Compensation (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Share-based Compensation data on file, last reported at $4.8 million in Q1 2026.

• On a quarterly basis, Share-based Compensation rose 15.72% year-over-year to $4.8 million in Q1 2026; TTM through Mar 2026 was $23.6 million, a 18.16% decrease from a year earlier, with the FY2025 full-year figure at $23.0 million, down 25.64% from the prior year.
• Share-based Compensation for Q1 2026 stood at $4.8 million, down from $7.1 million in the prior quarter.
• Over the last five years, Share-based Compensation for BLFS reached as high as $52.4 million in Q3 2022 and fell as low as $1.2 million in Q2 2022.
• Historically, Share-based Compensation has averaged $9.3 million across 5 years, with a median of $6.9 million in 2023.
• Across the five-year window, Share-based Compensation surged 1064.44% in 2022 and tumbled 82.6% in 2023, its largest moves.
• Year by year, Share-based Compensation stood at $7.7 million in 2022, then increased by 29.3% to $9.9 million in 2023, then gained by 7.91% to $10.7 million in 2024, then tumbled by 33.81% to $7.1 million in 2025, then slumped by 32.09% to $4.8 million in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $4.8 million in Q1 2026, $7.1 million in Q4 2025, and $5.9 million in Q3 2025.